Autolus Therapeutics plc American Depositary Share (AUTL) is a publicly traded Healthcare sector company. As of July 27, 2026, AUTL trades at $1.45 with a market cap of $385.91M and a P/E ratio of -1.33. AUTL moved -4.28% today. Year to date, AUTL is -26.40%; over the trailing twelve months it is -45.08%. Its 52-week range spans $1.11 to $3.22. Analyst consensus is strong buy with an average price target of $8.08. Rallies surfaces AUTL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for AUTL combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $1.45 |
| Market Cap | $385.91M |
| P/E Ratio | -1.33 |
| EPS | $-1.09 |
| Dividend Yield | 0.00% |
| 52-Week High | $3.22 |
| 52-Week Low | $1.11 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $92.62M |
| Net Income | $-288.96M |
| Gross Margin | -11.19% |
6 analysts cover AUTL: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $8.08.